Stocks / NASDAQ / CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.

Industry:   Health Care - Major Pharmaceuticals Stock Symbol:   CTMX - NASDAQ Animal Usage:   Animal Testing

Our Opinion

CytomX Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

The company announced in the following report that, “We anticipate filing an Investigational New Drug application (an “IND”), or similar regulatory filing, for CX-072 with the FDA or a foreign regulatory authority in the second half of 2016. CX-072 has in vivo efficacy comparable to published reference PD-L1-targeting antibodies in various animal models.” (Page 4) Read the full document.

Company Description

CytomX Therapeutics, Inc. operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer. The company was founded in September, 2010 and is headquartered in South San Francisco, CA. [Source: MarketWatch]

Company Website: http://cytomx.com

Contact:   http://cytomx.com/contact; IR: bgoeltz@cytomx.com;